McKesson Wins $31.6 Billion Veterans Agency Drug Contract
This article is for subscribers only.
McKesson Corp. won a Department of Veterans Affairs drug contract valued at as much as $31.6 billion over as many as eight years, the agency said in a statement today.
The San Francisco-based company has been the VA’s primary medicine supplier for veterans hospitals and the department’s mail-order pharmacies since 2004. McKesson, the largest U.S. drug distributor based on revenue, has received as much as $27 billion in orders under the current contract.